StockDriftsStockDriftsTop 2 Vida Ventures Advisors, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KYTX | KYVERNA THERAPEUTICS INC | 92.41% | 4.52M | $27.1M | +0.00%(+0) | $27.77(-66.15%) | 2025-09-30 | |
| ALLO | ALLOGENE THERAPEUTICS INC | 7.59% | 1.80M | $2.2M | +0.00%(+0) | $37.91(-96.36%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (12 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | -0.60% | -1.78% | — | — | -1.78% |
| Top 20 Holdings Unweighted | -13.43% | -35.12% | — | — | -35.12% |
Vida Ventures Advisors, Llc reports $29.37M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are KYTX (92.4%) and ALLO (7.6%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -1.78% on a three-year cumulative basis. Figures reflect the Q3 2025 filing.
Sign up free to track Vida Ventures Advisors, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Vida Ventures Advisors, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1831423). View Vida Ventures Advisors, Llc’s 13F filings on SEC